Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy

dc.contributor.author	Sargın, Zeynep Gök
dc.date.accessioned	2025-01-21T16:33:35Z
dc.date.available	2025-01-21T16:33:35Z
dc.date.issued	2023
dc.department	Kırıkkale Üniversitesi
dc.description.abstract	[Abstract No tAvailable]
dc.identifier.doi	10.5152/tjg.2023.23070
dc.identifier.endpage	309
dc.identifier.issn	2148-5607
dc.identifier.issue	3
dc.identifier.pmid	36919836
dc.identifier.scopus	2-s2.0-85150302022
dc.identifier.scopusquality	Q3
dc.identifier.startpage	308
dc.identifier.trdizinid	1169623
dc.identifier.uri	https://doi.org/10.5152/tjg.2023.23070
dc.identifier.uri	https://search.trdizin.gov.tr/tr/yayin/detay1169623
dc.identifier.uri	https://hdl.handle.net/20.500.12587/23807
dc.identifier.volume	34
dc.identifier.wos	WOS:001043949300016
dc.identifier.wosquality	Q4
dc.indekslendigikaynak	Web of Science
dc.indekslendigikaynak	Scopus
dc.indekslendigikaynak	TR-Dizin
dc.indekslendigikaynak	PubMed
dc.language.iso	en
dc.publisher	Aves
dc.relation.ispartof	Turkish Journal of Gastroenterology
dc.relation.publicationcategory	Diğer
dc.rights	info:eu-repo/semantics/openAccess
dc.snmz	KA_20241229
dc.title	Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
dc.type	Letter

Dosyalar

Listeleniyor 1 - 1 / 1